Over a period of 12 years, 1,039 patients were operated on at our hospital for gastroduodenal peptic ulcer. We analyzed the indications for surgery and divided the patients into two groups: subjects operated on for refractory ulcer, and patients operated on for an ulcer complication (bleeding, perforation or stenosis). To analyze the incidence of these indications for surgery, the 12 years of study (1976–1987) were divided into three 4-year periods. Our results show a statistically significant decline (p < 0.001) in the number of refractory ulcers after 1979, mainly concerning surgery for duodenal ulcer (p < 0.001). At the same time we witnessed a statistically significant increase (p < 0.001) in ulcer bleeding, again after 1979. This increase is particularly due to an increase in the incidence of duodenal ulcer bleeding (p < 0.001). Perforation did not undergo any statistically significant modifications over the three periods. Finally we witnessed a decrease in peptic stenosis, with a statistically significant decrease for gastric ulcer (p < 0.02).

Keywords:
Stomach, Gastric ulcer, Duodenal ulcer, Peptic ulcer bleeding, Ulcer perforation, Peptic pyloric stenosis
This content is only available via PDF.
© 1990 S. Karger AG, Basel
1990
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.